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Abstract
Radiotherapy (RT) plays a key role in cancer treatment. Although the benefit of ionizing radiation (IR) is well established,
some findings raise the possibility that irradiation of the primary tumor not only triggers a killing response but also increases
the metastatic potential of surviving tumor cells. Here we addressed the question of whether irradiation of normal cells
outside of the primary tumor augments metastasis by stimulating the extravasation of circulating tumor cells. We show that
IR exposure of human endothelial cells (EC), tumor cells (TC) or both increases TC-EC adhesion in vitro. IR-stimulated TC-EC
adhesion was blocked by the HMG-CoA reductase inhibitor lovastatin. Glycyrrhizic acid from liquorice root, which acts as a
Sialyl-Lewis X mimetic drug, and the Rac1 inhibitor NSC23766 also reduced TC-EC adhesion. To examine the in vivo
relevance of these findings, tumorigenic cells were injected into the tail vein of immunodeficient mice followed by total
body irradiation (TBI). The data obtained show that TBI dramatically enhances tumor cell extravasation and lung metastasis.
This pro-metastatic radiation effect was blocked by pre-treating mice with lovastatin, glycyrrhizic acid or NSC23766. TBI of
mice prior to tumor cell transplantation also stimulated metastasis, which was again blocked by lovastatin. The data point to
a pro-metastatic trans-effect of RT, which likely rests on the endothelial radiation response promoting the extravasation of
circulating tumor cells. Administration of the widely used lipid-lowering drug lovastatin prior to irradiation counteracts this
process, likely by suppressing Rac1-regulated E-selectin expression following irradiation. The data support the concern that
radiation exposure might increase the extravasation of circulating tumor cells and recommend co-administration of lipid-
lowering drugs to avoid this adverse effect of ionizing radiation.
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Introduction
Ionizing radiation (IR) is frequently used in cancer therapy to
achieve local tumor control. Despite of the enormous merit of
radiotherapy in the treatment of malignant diseases, it is well
known to cause not only tumor cell death but also normal tissue
damage that results in inflammation and fibrosis [1,2]. Another
side effect of IR rests on its ability to change the geno- and
phenotype of tumor cells that have survived radiation exposure,
leading to increased malignancy. Thus, in vitro studies demon-
strated a gain of motility, adhesion and invasiveness of tumor cells
upon irradiation, which are based on complex changes in gene
expression, among others the up-regulation of matrix metallopro-
teinases (MMP) [3,4,5,6,7]. A variety of preclinical in vivo studies
suggest that IR-induced stress responses of surviving tumor cells
might promote their invasive potency [8,9,10,11]. Moreover, pro-
angiogenic effects of ionizing radiation have been reported [12],
although a report exists claiming the opposite to be the case [13].
Occasional observations in patients are assisting the concern of
adverse pro-metastatic radiation effects [14,15,16]. Therefore,
failure to achieve local tumor control is suspected to promote the
dissemination of single tumor cells from the primary tumor and
their subsequent invasion into the normal tissue. The clinical
importance of the pro-metastatic radiation effect is controversially
discussed [17,18].
Apart from tumor cells, the normal tissue is also exposed to
radiation, e.g. during prophylactic cranial irradiation (PCI) or
when large parts of the body are irradiated, e.g. for the treatment
of Hodgkins disease or for palliative purposes. Low dose exposure
of normal cells is even unavoidable in the course of local tumor
irradiation. It is conceivable, yet poorly investigated to date, that
irradiation of the normal tissue might also stimulate metastasis.
This could occur for example by enhanced extravasation of tumor
cells that are circulating in the blood at the time of radiotherapy.
This possible side effect of radiotherapy, which has not been
addressed yet, might be evoked by upregulation of endothelial
adhesion factors required for the binding and extravasation of
malignant cells. In this process, endothelial selectin (E-selectin),
which is upregulated by IR both on the level of the mRNA and
protein [19,20], is of particular importance [7,21] as it mediates
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express sialylated carbohydrate structures operating as E-selectin
ligands [21,22,23,24,25].
A key response of both normal and tumor cells to IR is the
activation of the transcription factor nuclear factor-kappaB (NF-
kB) [26,27], which regulates cell survival [28,29] and inflamma-
tion [30,31]. Bearing in mind that the expression of a variety of
cell adhesion molecules [32,33], including E-selectin [34,35],
depends on the transcription factor NF-kB, pharmacological
interference with IR-induced activation of NF-kB is a rational
strategy for modulating non-beneficial radiation responses of
normal tissue. Previously, we showed that HMG-CoA reductase
inhibitors (statins), which are widely used in the clinic for lipid
lowering reasons, are able to attenuate the endothelial activation
of NF-kB provoked by inflammatory cytokines and IR [7,36]. This
statin effect rests on the inhibition of the activity of Ras-
homologous (Rho) GTPases [37] that are key regulators of NF-
kB [38].
Here we addressed the questions of whether (i) IR can enhance
the binding of tumor cells to the endothelium thus assisting
metastasis and (ii) statins are able to mitigate IR-stimulated
metastatic processes. We show that IR stimulates tumor cell-
endothelial cell adhesion in vitro, which is based on the
upregulation of pro-adhesive factors in both tumor and endothelial
cells. We extended these studies to an in vivo model of metastasis.
The data revealed that whole body irradiation of mice that had
been transplanted with tumorigenic cells by intravenous injection
leads to a significant increase in lung metastases as compared to
non-irradiated animals. We further provide evidence that the IR-
stimulated extravasation and metastasis can be antagonized by
pre-administration of the lipid lowering drug lovastatin.
Results and Discussion
Pro-adhesive radiation responses of human tumor and
endothelial cells are affected by lovastatin in vitro
Previously, we reported a pro-adhesive IR response of human
endothelial cells (EC), which is due to the upregulation of
endothelial adhesion molecules, in particular E-selectin, via NF-
kB [7]. Here, we expand on this observation showing that
irradiation of HT29 human colon carcinoma cells (TC) increases
their binding to human umbilical vein endothelial cells (HUVEC)
in vitro. Tumor cell-endothelial cell (TC-EC) adhesion following
irradiation of tumor cells occurred in a dose dependent manner
(Fig. 1A). Irradiation of both tumor and endothelial cells exerted
additive effects (Fig. 1B). Similar pro-adhesive effects were
obtained after irradiation of tumorigenic rodent cells (i.e. CHO-
K1 cells; see Figure S1). Whereas pre-treatment of HUVEC with
the lipid lowering drug lovastatin attenuated TC-EC adhesion,
pre-treatment of tumor cells with lovastatin was ineffective
(Fig. 1C). This indicates that the anti-adhesive effect of lovastatin
mainly rests on a reduced upregulation of endothelial adhesion
factors following radiation exposure. Similar to IR, treatment of
HT29 cells with the pro-inflammatory cytokine TNFa, which is
Figure 1. Irradiation of both endothelial and tumor cells stimulates TC-EC adhesion that is attenuated by lovastatin. A: Human colon
carcinoma cells (HT29) were irradiated with 2–10 Gy. 4 h later, adhesion to primary human endothelial cells (HUVEC) was analyzed as described in
Methods. Relative cell adhesion in untreated control was set to 1.0. *p#0.05, **p#0.01 (n=15). B: Human colon carcinoma cells (HT29) or endothelial
cells (HUVEC) were irradiated with 5 Gy. 4 h later, TC-EC adhesion was analyzed as described in Methods. **p#0.01 (n=8). C: Human colon carcinoma
(HT29) and/or endothelial cells (HUVEC) were left untreated or were pretreated overnight with lovastatin (10 mM) (Lova). Afterwards, cells were
irradiated (10 Gy) (IR) and TC-EC interactions were assayed after further incubation period of 4 h as described in Methods. See also Figure S1 and S2.
***p#0.001; **p#0.01 (n=8). D: Logarithmically growing human endothelial (HUVEC) or tumor cells (HT29) were left untreated or were pretreated
overnight with lovastatin (Lova). Afterwards cells were irradiated (IR) with 10 Gy and harvested 2 h or 4 h later for analysis of mRNA expression of
various cell adhesion molecules. GAPDH mRNA expression was determined as internal loading control.
doi:10.1371/journal.pone.0026413.g001
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EC adhesion (see Figure S2A). We also show that TC-EC
adhesion following TNFa treatment of HUVEC [7], was further
enhanced when the colon carcinoma cells were irradiated (see
Figure S2B and S2C). Whether treatment of either HUVEC or
HT29 cells with TNFa plus IR ameliorates TC-EC adhesion as
compared to a single treatment remains to be tested. Regarding
HUVEC, such additivity might be expected since we observed
TNFa and IR to have additive effects on the expression level of E-
selectin protein [7]. Overall, the data indicate that activation of the
transcription factor NF-kB, either by TNFa or ionizing radiation,
is of relevance for TC-EC adhesion.
Lovastatin mitigates IR-induced expression of cell
adhesion molecules in endothelial cells
To ascertain which cell adhesion molecules are most relevant
for the IR-stimulated increase in TC-EC adhesion and the
inhibitory effect of lovastatin, the mRNA expression levels of a
subset of cell adhesion molecules were analyzed. In endothelial
cells, IR increased the mRNA levels of E-selectin, VCAM and
ICAM-1 (,5.2-fold) (Fig. 1D) and IR-induced expression was
largely blocked by lovastatin (Fig. 1D). We assume that protein
expression is altered accordingly since we found in a previous
study that changes in the mRNA levels of E-selectin and ICAM-1
are accompanied by congruent alterations in the amounts of
protein [7]. In tumor cells, IR increased the mRNA expression of
genes coding for CD44 (,2.2-fold), LAMP2 (,1.7-fold) and
CXCR4 (,3.1-fold), which are described as E-selectin specific
counter-ligands [39,40] (Fig. 1D). Notably, their mRNA expres-
sion level was not affected by lovastatin (Fig. 1D). This is in line
with the observation that lovastatin pre-treatment of tumor cells
did not impact TC-EC adhesion. Whether CD44, LAMP2 and/or
CXCR4 are functionally involved in TC-EC adhesion stimulated
by ionizing radiation is still unclear. Recently it has been reported
that IR promotes the sialylation of integrin beta 1 [6]. Since
sialylated proteins are discussed as E-selectin counter-ligands [25],
it is conceivable that stimulation of TC-EC adhesion following
irradiation of tumor cells might result from changes in the post-
translational modification of pro-adhesive molecules rather than
an increase in de novo protein synthesis. Overall, the data show that
simultaneous irradiation of TC and EC has an additive effect on
TC-EC adhesion in vitro. This is likely due to a concomitant
upregulation of adhesion molecules in endothelial cells and
corresponding counter-ligands in tumor cells.
Ionizing radiation stimulates tumor cell extravasation and
formation of lung metastases in mice
Binding of circulating tumor cells to the endothelium is a
prerequisitefor their extravasationin vivo. Hence, the in vitro data are
alarming because they implicate that radiotherapy might promote
metastasis in vivo. To scrutinize this hypothesis we performed
experiments using different mouse models. We showed that total
body irradiation (TBI) of Balb/c mice results in the upregulation of
both E-selectin and ICAM-1 mRNA levels (Fig. 2A), which was
accompanied by activation of NF-kB (Fig. 2B). This is fully in line
with other experimental systems demonstrating activation of NF-kB
and subsequent expression of E-selectin and ICAM mRNA and
protein by IR [20,34,35,41]. Next, we determined whether TBI
promotes extravasation and metastasis. To this end, tumorigenic
Chinese hamster (CHO-K1) cells, which were shown to have
significant metastatic potential [42], were injected into the tail vein
of immunodeficient mice (Rag
22/2 Balb/c strain). In our hands,
CHO-K1 cells turned out to be the most appropriate cell line in this
mouse model. Other cell lines tested were not metastatic at all or
showed too high basal level of metastasis (see Figure S4).
Immediately after injection, mice were subjected to TBI with a
single dose of 4 Gy and colonization of the lung with metastases was
analyzed 3–4 weeks later in comparison with non-irradiated
animals. As shown in Fig. 2C, TBI caused a dramatic increase in
the formation of lung metastases and, to a lesser extent, also
increased the formation of liver metastases. Apparently, TBI
increases the likelihood of extravasation of circulating tumor cells
into the lung vasculature and subsequent formation of lung
metastases. The pro-metastatic effect of TBI was further illustrated
using CHO-K1 cells for transplantation that overexpress the red
fluorescent protein (Fig. 2D) or the luciferase protein (Fig. 2E). Lung
metastasis was also quantitated after intravenous injection of b-Gal
overexpressing CHO-K1 cells followed by the analysis of b-
galactosidase activity in protein extracts prepared from the lung of
irradiated versus non irradiated mice. These studies revealed that
TBI following transplantation of tumorigenic cells stimulated lung
metastasis by about 4–5-fold (Fig. 2F). The pro-metastatic effect of
TBI was also demonstrated by calculating the tumor area in lung
sections, which was significantly enhanced as compared to non-
irradiated mice (Fig. 2G). The data clearly show that TBI of mice
harbouring circulating tumor cells leads to a massive colonization of
the lung with metastases. Since extravasation of circulating
tumorigenic cells is a prerequisite for the formation of lung
metastases and, as shown above, TC-EC adhesion is stimulated
by IR, we conclude that TBI promotes the process of tumor cell
extravasation. With respect totheclinical situation, thedata point to
the possibility that the well established and highly appreciated
therapeuticeffectofradiotherapy(i.e.killingoftumorcells)mightbe
influenced by an increased probability of circulating tumor cells,
which have survived irradiation, to extravasate and develop tumors
at secondary sites.
Lovastatin counteracts IR-induced metastasis in mice
In search of drugs counteracting the putative pro-metastatic
effect of IR, we explored the HMG-CoA reductase inhibitor
lovastatin. The rationale behind this is that statins, which are
widely used as lipid-lowering drugs, block the Rac1-regulated and
NF-kB-dependent expression of E-selectin following TNFa or IR
exposure of endothelial cells in vitro [7,36]. Lovastatin mitigates
TC-EC interaction in vitro (see Fig. 1) and inhibits activation of NF-
kB following irradiation in vitro [7] and in vivo [43]. Moreover,
statins alleviate normal tissue damage (i.e. pro-inflammatory and
pro-fibrotic radiation responses) that results from radiotherapy as
acute or delayed side effect [44,45,46,47]. In agreement with our
in vitro data, lovastatin impaired the TBI-induced upregulation of
cell adhesion molecules in vivo (Fig. 3A). Most importantly, short-
time pre-treatment of Rag
22/2 Balb/c animals for 2 days with
lovastatin clearly attenuated the TBI-induced formation of lung
metastases (Fig. 3B). We should note that lovastatin does not
increase the sensitivity of CHO-K1 cells to irradiation [48].
Assaying b-galactosidase activity in lung extracts, which was taken
as indication of the tumor burden, we calculated that lovastatin
reduced the TBI-stimulated formation of lung metastases by about
75% (Fig. 3C). Amazingly, under these experimental conditions of
short-time pre-treatment with lovastatin, the statin had a weak
prometastatic effect on its own (see Figure S3). Extending the pre-
treatment period with lovastatin for 14 days, the prometastatic
statin effect was largely vanished and TBI-stimulated lung
metastasis was completely blocked (Fig. 3D). Pre- and post-
treatment with lovastatin had the same anti-metastatic effect as
pre-treatment alone (Fig. 3D), showing that (i) pretreatment with
lovastatin is sufficient to block metastasis and (ii) post-treatment
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adverse effects with respect to metastasis.
In order to elucidate whether TBI was effective in stimulating
metastasis when the animals, but not the tumor cells were
irradiated, mice were irradiated first and thereafter tumor cells
were transplanted. As shown in Fig. 4A, TBI of animals followed
by transplantation of non-irradiated tumor cells also resulted in
enhanced formation of lung metastases as compared to mice that
have not been pre-irradiated. When the animals were pre-treated
with lovastatin before they were subjected to TBI and then
received non-irradiated tumor cells, the formation of lung
metastases was reduced (Fig. 4B). These findings show that the
pro-metastatic effect of TBI is a trans-effect, i.e. it is due to a
radiation response of the normal tissue that stimulates the
metastatic properties of the tumor cells. It is reasonable to suggest
that this occurs via transient activation of pro-adhesive endothelial
functions. Pre-treatment of mice with lovastatin is sufficient to
block this pro-adhesive radiation response of the endothelium and,
therefore, antagonizes IR-mediated extravasation of tumor cells
and formation of lung metastases.
Whether TBI promotes lung metastasis of human tumor cells
could not be addressed in the Rag
22/2 Balb/c mouse model since
none of the human tumor cell lines tested (see Figure S4) formed
lung metastases in this host. Therefore, we transplanted human
HT29 colon carcinoma cells into CB-17 SCID mice where they
formed lung metastases with a low basal frequency. Because SCID
mice are radiosensitive, which is due to a defect in DNA repair
[49], it was necessary to irradiate the animals with lower IR doses.
It can be assumed that this dose reduction has a negative impact
on the pro-metastatic response of the animals and, therefore, the
SCID-based model was applied for confirmatory purpose only.
Despite these limitations, the results fully confirmed the data
Figure 2. Total body irradiation triggers tumor cell extravasation and lung metastasis in vivo. A: Balb/c mice were irradiated (IR) with 6
Gy. 4 h after total body irradiation (TBI) mRNA expression of cell adhesion molecules was analyzed in large blood vessels from pulmonary and
abdominal artery by RT-PCR. GAPDH mRNA expression was measured as internal loading control. As a positive control, isolated blood vessels were
incubated with TNFa (10 ng/ml, 30 min, 37
oC). B: Balb/c mice were subjected to TBI (6 Gy). 4 h after radiation (IR), phosphorylation of NF-kB inhibitor
IkBa (p-IkBa), which is indicative of activation of NF-kB, was analyzed in liver extracts by Western blot analysis. ERK2 protein expression was
determined as internal loading control. C: 2610
6 CHO-K1 cells were injected into the tail vein of immunodeficient Rag
22/2 Balb/c mice. Immediately
after injection, mice were irradiated (4 Gy) (TBI). 3–4 weeks after TBI, the formation of metastases was analyzed in lung and liver. TC, tumor cells
injected; TBI, total body irradiation. Shown are representative morphological and histopathological pictures (2–4 animals were analyzed per group).
D: Red fluorescent protein overexpressing CHO-K1 cells were used for injection into the tail vein of immunodeficient Rag
22/2 Balb/c mice. Formation
of lung metastases was analyzed 3–4 weeks after TBI with 4 Gy. Con, non-irradiated control; IR, TBI with 4 Gy. Shown are representative pictures (2–3
animals were analyzed per group). E: Four weeks after i.v. injection of luciferase overexpressing CHO-K1 cells followed by TBI (4 Gy), luciferase activity
in the lung was monitored by use of a life imaging instrument as described in Methods. Shown are representative pictures (2–3 animals were
analyzed per group). F: 3–4 weeks after i.v. injection of b-galactosidase (b-Gal) overexpressing CHO-K1 cells followed by TBI (4 Gy), relative b-Gal
activity in lung extracts of irradiated mice was related to that of non irradiated control mice, which was set to 100%. **p#0.01 (n=4–8 mice). G:
Formation of lung metastasis was quantitated in the lung of irradiated versus non-irradiated mice by calculating the % tumor area as related to the
total lung area. Con, non-irradiated control; IR, TBI with 4 Gy. ***p,0.001 (n=4–8 mice).
doi:10.1371/journal.pone.0026413.g002
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22/2 system. Thus, we observed
that TBI with 2.5 Gy promotes lung metastasis after i.v. injection
of HT29 cells into CB-17 SCID mice (Fig. 4C). Moreover,
lovastatin pre-treatment largely neutralized TBI-stimulated for-
mation of lung metastases in the HT29 cells/SCID mouse model
(Fig. 4D). Taken together, we were able to show using two
experimental in vivo model systems (i.e. rodent CHO-K1 cell/
Rag
22/2 Balb/c mice and human HT29 cell/CB-17 SCID mice)
that TBI stimulates the extravasation of circulating tumor cells and
subsequent formation of lung metastases and that this effect is
attenuated by lovastatin. The in vivo data thus support the notion of
a pro-metastatic potency of IR and the benefit of lovastatin in
blocking extravasation and metastasis.
E-selectin is involved in IR-induced tumor cell
extravasation and metastasis
Sialyl-Lewis X structures are known as major counter-ligands
of the endothelial adhesion molecule E-selectin [25,50]. They
have been shown to be of importance for the progression of colon
cancer [23]. To examine whether these tetrasaccharide carbo-
hydrates are involved in IR-stimulated TC-EC adhesion in vitro
and metastasis in vivo, we made use of the Sialyl-Lewis X mimetic
glycyrrhizic acid (GL) [51], which is the major sweet tasting
compound of liquorice root. As shown in Fig. 5A, glycyrrhizic
acid largely blocked IR-induced binding of tumor cell to
endothelial cells, indicating that E-selectin and its ligand Sialyl-
LewisX are important for radiation-promoted TC-EC adhesion
in vitro. Next, we investigated the involvement of the E-selectin
counter-ligand Sialyl-Lewis X on TBI-driven extravasation and
metastasis in vivo. Fully in line with our in vitro data we observed
that pre-treatment of mice with GL largely attenuated the TBI-
induced extravasation and formation of lung metastases (Fig. 5C).
The data support the concept that E-selectin and its ligands are
essential for TBI-stimulated tumor cell extravasation and
metastasis.
Figure 3. Lovastatin attenuates IR-induced metastasis in vivo. A: Balb/c mice were pretreated with lovastatin (10 mg/kg, p.o.) and irradiated
with 6 Gy. 4 h after TBI, large blood vessels (i.e. pulmonary and abdominal artery) were isolated for total mRNA preparation and subsequent
semiquantitative RT-PCR. ICAM-1 mRNA expression levels shown in the histogram were obtained by real-time PCR analyses (triplicate
determinations). The level of ICAM-1 mRNA was normalized to the levels of GAPDH and b-actin and set to 1.0 in the untreated control (Con).
Con, non-irradiated control; IR, irradiation; IR+Lova, IR exposure after lovastatin pre-treatment. B, C: 2610
6 CHO-K1 cells were injected into the tail
vein of immunodeficient Rag
22/2 Balb/c mice which had been pre-treated or not with lovastatin (10 mg/kg, p.o.) for 2 days. Immediately after tumor
cell injection, mice were irradiated with 4 Gy (IR). Post-treatment with lovastatin was not performed. 3–4 weeks after TBI, formation of metastasis was
analyzed. B, IR, irradiation; IR+Lova, IR exposure after lovastatin pre-treatment. Shown are representative morphological and histopathological
pictures (from n=4–6 animals per group). C, The protective effect of lovastatin on IR-induced extravasation and lung metastasis of CHO-K1 cells was
quantitated by determination of b-Gal activity in protein extracts from lung. Relative b-Gal activity in untreated control was set to 100%. See also
Figure S3. **p#0.01 (n=4 mice). D: 2610
6 CHO-K1 cells were injected into the tail vein of immunodeficient Rag
22/2 Balb/c mice which had been
pretreated or not with lovastatin for 14 days (10 mg/kg, p.o., 3x per week). Immediately after tumor cell injection, mice were irradiated with 4 Gy (IR).
3–4 weeks later, the percent tumor area in lung sections was calculated as described in methods. IR, irradiation; IR+Lova, IR exposure after lovastatin
pre-treatment; L-I, lovastatin pre-treatment only; L-II, lovastatin pre- and post-treatment. Post-treatment (10 mg/kg, p.o., 3x per week) was performed
for 2 weeks. *** p#0.001 (n=4 mice per group).
doi:10.1371/journal.pone.0026413.g003
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IR-driven pro-metastatic processes
The E-selectin gene is known to be regulated by the
transcription factor NF-kB [35]. As mentioned above, the
Ras-homologous GTPase Rac1 is required for the activation of
NF-kBb yT N F a and IR [7,36]. Therefore, it is reasonable to
speculate that Rac1 signaling might interfere with the radiation-
induced TC-EC interaction in vitro and metastasis in vivo.I nl i n e
with this, we found that pharmacological inhibition of Rac1 by
NSC23766 [52] impairs the radiation-stimulated increase in
TC-EC adhesion in vitro (Fig. 5B). Most importantly, pre-
treatment of mice with NSC23766 also blocked TBI-induced
tumor cell extravasation and formation of lung metastases in vivo
(Fig. 5C and Fig. 5D). Therefore, we suggest that TBI-induced
extravasation of circulating tumor cells rests on Rac1/NF-kB-
dependent upregulation of endothelial adhesion molecules, in
particular E-selectin, and involves tumor specific E-selectin
ligands such as Sialyl-LewisX carbohydrates. Since Rho
GTPases, including Rac1, are known as highly relevant targets
of statins, we speculate that the observed protective effect of
lovastatin against TBI-induced extravasation and metastasis
rests on the inhibition of Rac1-NF-kB-regulated upregulation of
E-selectin.
In summary, we provide evidence that IR largely stimulates EC-
TC adhesion in vitro and that whole body irradiation of mice
increases the probability of extravasation and subsequent forma-
tion of lung metastases of transplanted circulating tumorigenic
cells of rodent and human origin. The pro-metastatic radiation
effect appears to rest on the upregulation of both endothelial and
tumor cell-specific adhesion factors (see Fig. 6). Importantly, the
radiation response is a trans-effect since irradiation of mice prior to
transplantation of non-irradiated tumor cells also stimulated
metastasis. From this we infer that irradiation of the normal tissue
is sufficient to trigger metastasis. Searching for pharmacological
strategies counteracting the adverse radiation effect, we show that
pre-administration of lovastatin, which is nowadays widely used as
lipid-lowering drug, can antagonize pro-adhesive radiation effects
in vitro and the pro-metastatic effects of TBI in vivo. The anti-
metastatic statin effect is very likely due to inhibition of IR-induced
normal tissue responses, in particular the IR-stimulated Rac-1-
regulated increase in the expression of endothelial cell adhesion
molecules (see Fig. 6). Thus, the proposed pharmacological
strategy suitable to counteract pro-metastatic effects of RT is
based on the inhibition of Rac1 signaling, either by statins (e.g.
lovastatin) or Rac1-specific inhibitors, such as NSC23766 (see
Fig. 6). Alternatively, radiation-stimulated binding of tumor cells
to the endothelium can be blocked by Sialyl-LewisX mimetic
Figure 4. Radiation response of normal tissue is sufficient for provoking lung metastasis. A, B: Rag
22/2 Balb/c mice that have been pre-
treated or not with lovastatin (Lova) for 4 days (10 mg/kg, p.o.) were irradiated with 4 Gy before tumorigenic (non-irradiated) CHO-K1 cells (2610
6)
were injected into the tail vein. 3–4 weeks later, formation of lung metastases was analyzed. A, representative morphological and histopathological
pictures demonstrating the pro-metastatic effect of TBI; B, quantitative analysis of tumor area in lung sections. Con, non-irradiated control; IR, TBI with
4 Gy. ** p#0.01; *** p#0.001 (n=4–8 mice). C, D: 2610
6 human colon carcinoma cells (HT29) were injected into the tail vein of CB-17 SCID mice
which have been pretreated or not with lovastatin (Lova) for 4 days (10 mg/kg, p.o.). Immediately after injection of the tumor cells, animals were
irradiated with 2.5 Gy. 3–4 weeks later, lung metastases were analyzed by calculating the tumor area as described in Methods. C, representative
morphological and histopathological pictures illustrating the IR effect; D, quantitative analysis of percent (%) tumor area in lung sections. Con, non-
irradiated control; IR, total body irradiation with 2.5 Gy; nd, no tumor cells detectable. * p#0.05 (n=3–4 mice). See also Figure S4.
doi:10.1371/journal.pone.0026413.g004
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neither Sialyl-LewisX mimetics nor Rac1 inhibitors have thus far
been established for clinical use. Therefore, we propose to focus on
statins that are clinically well established, very well tolerated and
widely used for lipid lowering purpose. We consider them as first
choice drugs for short-term clinical application.
Regarding speculations about the clinical relevance of the
findings, it is important to consider the question whether the local
concentration of circulating tumor cells in the lung vasculature is
high enough to achieve significant extravasation in humans, in
particular because radiation to the lung is kept to a minimum in
the clinic. Besides, although extravasation is essential for
metastasis, additional factors (e.g. motility, proliferation, vascular-
ization) are required to complete the formation of metastases.
Despite the complexity of the metastatic process, the data support
the concern raised in previous reports [11,12,14,16,18] that RT
might stimulate metastasis. This notion should not be taken as an
argument against the well-known therapeutic benefit of RT. It just
raises the point that, if tumor cells are not fully eradicated by RT,
there is the possibility of an increased level of extravasation and
metastasis in the survivors. This also pertains to prophylactic
irradiation. Although there is no clinical evidence that prophylac-
tic irradiation increases metastasis, a pro-metastatic potential
cannot be excluded. Thus, the data reported here support a
previous note that calls for a critical reassessment of the benefit of
prophylactic irradiation [17,53]. Apparently, further preclinical
studies are required using clinically more appropriate experimen-
tal settings, for example fractionated local irradiation of the lung
with low doses. Irrespective of this, we propose on the basis of the
data that the inclusion of statins into current radiotherapeutic
regimen is a reasonable strategy for improving the long-term
clinical outcome of radiation-based tumor therapy. Since statins
are widely used for lipid lowering purposes, the question regarding
the clinical relevance of our data might easily be addressed in
retrospective and/or prospective clinical studies in which statins
are administered concomitantly with RT.
Materials and Methods
Materials
For treatment of cells and animals with ionizing radiation (i.e. c-
rays), a
60Co source (Atomic Energy of Cananda Ltd.) was used.
Total RNA was isolated by use of E.Z.N.A. Total RNA Kit
(Omega Bio-Tek, Norcross, USA). cDNA synthesis was performed
using iScript
TM cDNA Synthesis Kit (Biorad, Munic, Germany).
TNFa, Calcein AM solution, glycyrrhizic acid and DNA oligos
originate from SIGMA-Aldrich (Taufkirchen, Germany). dNTPs,
the PCR Y-buffer, and nitrocellulose were from Perkin Elmer
(Rodgau, Germany). Orange Loading Dye Solution was obtained
from Fermentas (St. Leon-Rot, Germany). The Absolute QPCR
SYBR Green Fluorescein Mix was from Thermo Fisher (Schwerte,
Germany). ERK2 antibody used in this study was obtained from
Santa Cruz (Heidelberg, Germany), antibody for phosphorylated
IkBa (p-IkBa) originated from New England Biolabs (Frankfurt
am Main, Germany). Hyperfilm ECL was from GE Healthcare
(Mu ¨nchen, Germany). Taq DNA Polymerase was a kind gift of H.
Kleinert (Mainz, Germany). Lovastatin and Rac1 inhibitor
NSC23766 were purchased from Calbiochem-Novabiochem
(Bad Soden, Germany) and dissolved in ethanol for the in vitro
analyses. For the in vivo studies lovastatin was solubilized in 0.9%
saline and sonicated prior to oral administration or injection.
Figure 5. The small GTPase Rac1 and E-selectin ligands are involved in IR-induced TC-EC adhesion in vitro and TBI driven
extravasation of metastasis in vivo. A, B: Human colon carcinoma cells (HT29) and/or endothelial cells (HUVEC) were left untreated or were pre-
treated with the Sialy-Lewis X mimetic glycyrrhizic acid (2 mM, 30 min) (A) or the Rac1 inhibitor NSC23766 (100 mM, 4 h) (B). 4 h after irradiation (10
Gy), TC-EC adhesion was analyzed as described in methods. *p#0.05; **p,0.01 (n=8). C, D: CHO-K1 cells (2610
6) were injected into the tail vein of
Rag
22/2 Balb/c mice that have been pre-treated or not with glycyrrhizic acid (GL), NSC23766 (NSC). 3–4 weeks after TBI (4 Gy), formation of lung
metastases was analyzed. C, Representative morphological and histopathological photographs are shown. D, The histogram displays the percent (%)
tumor area in lung sections. Con, non-irradiated control; IR, TBI with 4 Gy. ** p#0.01; *** p#0.001 (n=4–8 mice).
doi:10.1371/journal.pone.0026413.g005
Lovastatin Inhibits IR-Triggered Metastasis
PLoS ONE | www.plosone.org 7 October 2011 | Volume 6 | Issue 10 | e26413Primary cultures of human umbilical vein endothelial cells
(HUVEC) were obtained from Lonza Sales Ltd (Basel, CH).
Cell culture conditions
Cells of rodent origin (CHO-K1 hamster fibroblasts [54] and
B16F10 mouse melanoma cells [55]) and human tumor cells
(HT29 colon carcinoma cells [56], MCF-7 and T47D mammary
carcinoma cells [48]) were grown in RPMI medium containing
10% fetal bovine serum (FBS) supplemented with penicillin and
streptomycin. Human DLD-1 colon carcinoma cells (originating
from the American Type Culture Collection (ATCC)) were
cultured in DMEM plus 10% FBS. Primary human umbilical
vein endothelial cells (HUVEC) (purchased from Cambrex (Bio
Whittaker Europe)) were cultured in endothelial cell growth media
system (EGM-2; Lonza Ltd, Basel, CH) containing 2% FCS,
0,04% hydrocortisone, 0,4% hFGF-B, 0,1% VEGF, 0,1% R
3-
IGF-1, 0,1% Ascorbic acid, 0,1% hEGF, 0,1% GA-1000 and
0,1% heparin). HUVEC were used in the 4th to 10th passage for
the experiments. Cultures were kept at 37uC in humidified
atmosphere containing 5% CO2.
Total RNA purification and RT-PCR reaction
1 mg of purified total RNA was used for cDNA synthesis.
Reverse transcription was performed at 25uC for 5 min, 42uC for
30 min and 85uC for 5 min. For PCR reaction 30 cycles were
performed (denaturation: 94uC, 1 min; annealing: 60uC, 2 min;
polymerization: 68uC, 2 min). PCR products were separated onto
agarose gels and DNA was visualized by ethidium bromide
staining. The sequence of the sense (s) and antisense (as) primers
used for amplification reactions were as follows: E-selectin, f:
TCTCTCAGCTCTCACTTTG, r: TTCTTCTTGCTGCACC-
TCT (384 bp); VCAM, f: AATTTATGTGTGTGAAGGAG, r:
GCATGTCATATTCACAGAA (466 bp); ICAM, f: GGCTG-
GAGCTGTTTGAGAAC, r: ACTGTGGGGTTCAACCTCTG
(202 bp); LAMP-2, f: GGTTAATGGCTCCGTTTTCA, r: AT-
GGGCACAAGGAAGTTGTC (216 bp); CD44, f: AGAAG-
GTGTGGGCAGAAGAAAA, r: CATTCTGCAGGTTCCTT-
GTCT (187 bp); TIMP, f: ATTCCGACCTCGTGATCAG, r:
CGTCCACAAGCAATGAGTG (405 bp); CXCR4, f: GGT-
GGTCTATGTTGGCGTCT, r: TGGAGTGTGAC AGCTTG-
GAG (227 bp); CXCL12, f: CTTTAGCTTCGGGTCAATGC,
r: TCAGCCTGAGCTACAGATGC (161 bp); b1-Integrin, f:
CGAGGTCATGGTTCATGTTG, r: CAGTGTTGTGGGAT-
TTGCAC (294 bp); b3-Integrin, f: GACAAGGGCTCTGGA-
GACAG, r: ACTGGTGAGCTTTCGCATCT (231 bp); GA-
PDH, f: GAAGATGGTGATGGGATTTC, r: GAAGGTGAA-
GGTCGGAGTC (313 bp). Real-time PCR was performed using
the Absolute QPCR SYBR Green Fluorescein Mix (Thermo
Fisher) and a MyIQ Thermal Cycler (BioRad). For each reaction,
2 ml of diluted (1:10) cDNA and specific primers (0,06 mM each)
were used. After denaturation step (95uC, 15 min), PCR reaction
(40 cycles) was conducted according to the following proto-
col:95uC, 30 sec; 60uC, 1 min; 72uC, 1 min. At the end of each
reaction, the melting curve was recorded to ensure the specificity
of the reaction. From each sample, real-time PCR analysis was
performed in duplicate or triplicate. Data were analyzed using
IQ5 Optical System Software 2.0 (BioRad). The sequence of the
sense (s) and antisense (as) primers used for amplification reactions
were created using the Primer3 software. GAPDH, f: AACT-
TTGGCATTGTGGAAGG, r: CACATTGGGGGTAGGAAC-
AC (222 bp product); b-actin, f: GCATTGCTGACAGGATG-
CAG, r: CCTGCTTGCTGATCCACATC (159 bp); E-selectin, f:
AGCTACCCATGGAACACGAC, r: ACGCAAGTTCTCCAG-
CTGTT (199 bp); ICAM-1, f: CGAAGGTGGTTCTTCT-
GAGC, r: GTCTGCTGAGACCCCTCTTG (238 bp), CD44,
f: TGGATCCGAATTAGCTGGAC, r: AGCTTTTTCTTCT-
GCCCACA (189 bp).
Preparation of protein extracts, SDS PAGE and Western
Blot analysis
For preparation of total protein extracts 15 mg of the respective
organs were disrupted by Ultra-Turrax in lysis buffer (20 mM
TRIS, pH 7,5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA,
2,5 mM sodium pyrophosphate, 1 mM Na3VO4,1 mg/ml
Complete EDTA free (Roche), 1 mM PMSF, 1% Triton X-
100). Subsequently, samples were sonicated. After centrifugation
(10 min, 10.000 x g, 4
oC), the pellet was discarded and the
supernatant used for protein determination by Bradford and
subsequent Western Blot analysis. Protein extracts were separated
by SDS PAGE. Subsequently, proteins were transferred onto
nitrocellulose membranes (Perkin Elmer) using a Protean Mini
Cell (BioRad). After completion of the transfer, membranes were
blocked in 5% non-fat milk in TBS/0.1% Tween 20 for at least
60 min. Incubation with the primary antibody (as indicated) was
conducted overnight at 4uC. Incubation with peroxidase conju-
gated anti-mouse or anti-rabbit secondary antibody (1:2000)
(Rockland) was performed for 60 min at room temperature.
Bound antibodies were then visualized using a chemiluminescence
reaction and Hyperfilm ECL (GE Healthcare). For densitome-
Figure 6. Model of IR-induced tumor cell extravasation and
metastasis and pharmacological strategies to prevent this
adverse radiation effect. Ionizing radiation (IR) triggers the
expression of different types of cell adhesion molecules on tumor
(TC) and endothelial (EC) cells, which augment TC-EC adhesion and
subsequent extravasation of tumor cells. By inhibiting Rac1-regulated
activation of NF-kB, HMG-CoA reductase inhibitors (statins) specifically
attenuate IR-induced expression of endothelial cell adhesion molecules,
thereby antagonizing radiation-promoted adhesion of circulating tumor
cells as well as subsequent extravasation and formation of lung
metastases. TBI-promoted metastasis can also be reduced by targeting
of the small GTPase Rac1 using the small molecule inhibitor NSC23766
and/or the Sialyl-Lewis X mimetic glycyrrhizic acid, which acts as E-
selectin antagonist. CAF, cell adhesion factors; FPP, farnesylpyropho-
sphate; GGPP, geranylgeranylpyrophosphate; GL, Glycyrrhizic acid.
doi:10.1371/journal.pone.0026413.g006
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software (BioRad) was applied.
Analysis of cell adhesion
Tumor cell - endothelial cell adhesion (TC-EC adhesion) was
analyzed by an ELISA-based method as described [7]. Briefly,
cells were pretreated or not with lovastatin (10 mM) for 16h before
TNFa treatment or irradiation was performed. Tumor cells were
labeled with the fluorescent dye Calcein AM (5 mM, 30 min,
37uC) in RPMI containing 10% FCS. Cells were washed with PBS
and resuspended in RPMI containing 10% FCS. 5610
5 labeled
cells were added to confluent monolayers of HUVEC (human
umbilical vein endothelial cells), which have been stimulated or
not 4 h earlier with TNFa or c-rays, for 2 h at 37uC. After
removal of nonadherent cells by washing with PBS twice, the
attached cells were quantified by fluorimetric analysis (excitation
wavelength: 495 nm, emission: 517 nm). Relative adhesion of
non-stimulated tumor cells to non-stimulated endothelial cells was
set to 1.0. Data are shown as mean values 6 SD from 2–4
independent experiments each performed in quadruplicate (n$8).
For statistical evaluation Students t-test was used.
In vivo analyses
For in vivo experiments, immunodeficient Rag
22/2 Balb/c mice
(both provided by our local animal facility) were used. Mice were
bred in our local specific-pathogen free animal housing facility and
were 3–4 months of age at the start of the experiments. To analyze
the effect of lovastatin on early radiation responses, Balb/c mice
were pre-treated with lovastatin p.o. (10 mg/kg BW) for 2 days. At
day 3 the mice were irradiated with 6 Gy and sacrificed 4 h or
24 h later. Blood vessels (isolated from pulmonary and abdominal
artery) and organs were isolated for the analysis of mRNA and
protein expression. For analyzing the effect of total body
irradiation (TBI) on the extravasation and lung colonization of
circulating cells the CHO-K1 system, which is an accepted model
of metastasis [42], was routinely used. Cells were left untransfected
or were stably transfected with either a b-Gal (pcDNA3.1His/lacZ
(Invitrogen, Karlsruhe, Germany)), luciferase expression vector
(pGL2-basic (Promega, Mannheim, Germany)) or pTurboFP635-
C Vektor (Evrogen, Moscow, Russia) and injected into the lateral
tail vein of immunodeficient Rag
22/2 Balb/c mice (2610
6 cells/
0.25 ml PBS/mouse). Lovastatin pre-treatment of the mice
(10 mg/kg, p.o. or i.p.) was performed for different period of
time (2d – 14d). Immediately after injection of the tumor cells,
animals were irradiated (total body irradiation) with 4 Gy. TBI
was used as a proof-of-principle approach to assess the role of
radiation on metastasis. 4 weeks later animals were sacrificed and
organs, in particular the lung, were examined macroscopically for
the presence of metastases. Lung tissue from each animal as well as
any other tissue containing macroscopically detectable metastases
were fixed in formaldehyde or frozen in liquid nitrogen for
pathological examinations and biochemical analyses, respectively.
Glycyrrhizic acid was applied twice, i.e. 24 h (10 mg/kg; i.p.) and
0.5 h (5 mg/kg; i.p.) before TBI. The Rac inhibitor NSC23766
(5 mg/kg; i.p) was given 48 h and 24 h before TBI. Data shown
are mean values 6 SD based on the results of at least 2–4
independent experiments with 2–4 animals per group in each
experiment (total number of animals 4–8). Statistical significance
was calculated using Students t-test. For confirmation of the
results, a second independent model system, consisting of
immunodeficient CB-17 SCID mice that were irradiated with
2.5 Gy after injection of human colon carcinoma cells (HT29), was
used. Under our experimental conditions, the mice behaved
normal throughout the experiment and did not show major signs
of toxicity such as loss of weight or scrubby coat. All animal work
performed in this study was conducted according to the national
guidelines and was reviewed and approved by an institutional
review board/ethics committee headed by the local animal welfare
officer (Prof. Kempski) of the University Medical Center (Mainz,
Germany). The animal experiments were additionally approved
by the responsible national authority, which is the National
Investigation Office Rheinland-Pfalz (Koblenz, Germany). The
Approval ID assigned by this authority is the following: AZ 23177-
07/G09-1-023.
Histology and quantitative assessment of lung metastasis
Formaldehyde-fixed paraffin-embedded samples were cut into
sections of 4 mm thickness and stained with haematoxylin and
eosin (HE staining). To quantify the amount of metastases the
expression of b-galactosidase activity was quantified in lung
extracts using the Beta-Glo assay (Promega, Mannheim, Ger-
many). To this end, lung tissue was homogenized with an
ultraturrax and sonicated in sonication buffer (20 mM Tris-HCl,
pH 8,5, 1 mM EDTA, 1 mM b-mercaptoethanol and 5%
glycerol). Cell debris was removed by centrifugation (109,
10000xg, 4uC). Supernatant was used for measuring the protein
concentration according to Bradford before Beta-Glo Assay was
performed according to the manufacturers protocol (Promega,
Mannheim, Germany). In the reaction, 6-O-b-galactopyranosyl-
luciferin serves as a substrate which is cleaved by b-galactosidase to
yield luciferin which is metabolized by luciferase. Bioluminescence
was detected using a luminometer (Berthold detection systems,
Pforzheim, Germany). The b-gal activity was expressed as relative
light units (RLU) and was set to 100% in non-irradiated controls.
The fraction of tumor tissue in the lung was also quantitated in
HE-stained lung sections ($3 sections per lung/animal) by
calculating the percentage of tumor tissue in relation to the
normal tissue by use of imaging technique (Photoshop 7.0).
In vivo imaging
Luciferase overexpressing CHO-K1 cells (2610
6) were injected
into the lateral tail vein of Balb/c Rag
22/2 mice. 4 weeks after
TBI with 4 Gy, 100 ml of luciferin solution (15 mg/ml in PBS
(Promega)) was injected intraperitoneally. Ten minutes later mice
were anesthetized by isoflurane and placed ventral side up in an
IVIS Lumina II live image instrument (Caliper, Ru ¨sselsheim,
Germany). Images of luciferase activity were continuously
acquired until maximal activity was detected. The acquired
images were analyzed using the Living Image 3.0 software.
Supporting Information
Figure S1 IR stimulates the adhesion of CHO-K1 cells
to HUVEC. Chinese hamster ovary cells (CHO-K1) and/or
endothelial cells (HUVEC) were left untreated or were pretreated
overnight with lovastatin (10 mM) (Lova). Afterwards, cells were
irradiated (10 Gy) (IR) and TC-EC interactions were assayed after
further incubation period of 4 h as described in Methods.
1irradia-
tion after lovastatin pretreament. ** p#0.01 (n=4).
(TIF)
Figure S2 Ionizing radiation promotes TNFa-provoked
TC-EC adhesion. A: TNFa treatment of both tumor cells
(HT29) or endothelial cells (HUVEC) promotes TC-EC adhesion.
Pretreatment with TNFa (10 ng/ml) was performed for 4 h.
*p#0.05; **p#0.01 (n=8). B, C: Endothelial cells (HUVEC) were
left untreated or were treated with TNFa (10 ng/ml) for 4 h.
Human colon carcinoma cells (HT29 (B) or DLD-1 (C)) or were
irradiated with 2–10 Gy. 4 h after irradiation, tumor cells were
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adhesion was measured as described in Methods. *p#0.05;
**p#0.01 (n=9–15).
(TIF)
Figure S3 Effect of lovastatin on the formation of lung
metastases. 2610
6 CHO-K1 cells were injected into the tail
vein of Rag
22/2 BALB/c mice which had been pretreated with
lovastatin p.o. or i.p. for different periods of time. The formation
of lung metastases was analyzed three weeks later. +, weak effect;
++, stronger effect. As further control, physiological NaCl solution
was administered p.o. Data shown are based on the morphological
analysis of n=3–4 animals per experimental condition.
(TIF)
Figure S4 Cell line specificity of formation of lung
metastases. 2610
6 cells were injected into the tail vein of
Rag
22/2 BALB/c mice. Afterwards mice were irradiated with 4
Gy (total body irradiation). The formation of lung metastases was
analyzed three weeks later. Control, non-irradiated; IR, total body
irradiation; -, no lung metastases detectable; +, weak effect; +++,
strong effect. Data shown are based on the morphological analysis
of n=3–4 animals per cell line used.
(TIF)
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